ClinicalTrials.gg
RecruitingNCT07594600FIBRE-MATCHUpdated Jun 4, 2026

The Effect of Low or High Dietary Fiber Diet on Volatile Organic Compounds in Exhaled Breath of Healthy Individuals

An interventional study of Low, High Fiber Diet and High, Low Fiber Diet in Healthy Adults and Dietary Fiber Fermentation, sponsored by Örebro University, Sweden. Recruiting at 1 site in Sweden. Open to participants aged 18 Years to 65 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-06-04.

Sponsored by Örebro University, Sweden · Not applicable, Interventional, and Basic science

Phase
Not applicable
Study type
Interventional
Enrollment
20
Allocation
Randomized
Ages
18 Years to 65 Years
Sex
All
01

Study summary

The aim of this crossover intervention study is to evaluate the volatile organic compounds (VOCs) present in participants at baseline and how these levels change after consuming either a low- or high-dietary fiber diet for three days. This study will involve adults, 18-65 years old, without any gastrointestinal diseases.

The primary objectives are to characterize baseline VOC profiles, assess changes in these profiles after a short-term dietary fiber intervention, determine if specific VOC patterns correlate with dietary fiber intake, and identify the time points at which VOC levels peak. This information will help establish the optimal timing for breath sampling and potentially provide insight into how VOC patterns relate to dietary fiber consumption and degradation.

The expected outcome is that a high-dietary fiber diet will produce a VOC profile enriched in metabolites associated with fiber fermentation compared to a low-dietary fiber diet, and that these VOCs will be consistent with those identified in vitro during fecal fermentation. Each participant will serve as an internal control, enabling within-subject comparisons of VOC levels at baseline and following the dietary fiber intervention.

Participants will receive a whole-food product that is rich in dietary fiber and will consume either a low-fiber diet (10 g/day) or a high-fiber diet (40 g/day) for three days. On the first day of each intervention, participants will also ingest a pH capsule to monitor gastrointestinal pH continuously throughout the three days. After a three-week washout period, participants will cross over to the other intervention arm and undergo another round of gastrointestinal pH monitoring.

In addition to the dietary intervention, participants will complete food and health questionnaires to assess habitual fiber intake and dietary habits. Fecal samples will be collected for in vitro fermentation to functionally profile the gut microbiota by assessing fecal VOCs, short-chain fatty acids (SCFA), and the microbial enzymatic activity and its pH-dependent modulation.

02

Conditions studied

  • Healthy Adults
  • Dietary Fiber Fermentation

Keywords

  • Volatile Organic Compounds
  • Food Intervention
  • Healthy participants
  • No gastrointestinal diseases
  • Without gastrointestinal diseases
  • Dietary Fiber
03

In context

Lead sponsor

Örebro University, Sweden is the lead sponsor of 86 studies on the registry; 14 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. Signed obtained prior to any study-related procedures.
  2. Willingness to refrain from regular consumption of prebiotic or probiotic products, as well as medications known to affect gastrointestinal function, for at least four weeks prior to the study visits.

Exclusion criteria

Exclusion Criteria:

  1. History of complicated gastrointestinal surgery.
  2. Presence of a gastrointestinal diagnosis or any condition that, in the opinion of the principal investigator, may influence the study outcomes.
  3. Current diagnosis of a psychiatric disorder.
  4. Systemic use of antibiotics or medications within the past 3 months.
  5. Frequent use of NSAIDs (non-steroidal anti-inflammatory drugs) within the 2 months preceding the study visit.
  6. Regular consumption of prebiotic or probiotic products within the past 4 weeks.
  7. Alcohol or substance abuse.
  8. Current smoking or use of nicotine pouches.
  9. Frequent use of laxatives, antidiarrheal agents, or anticholinergic medications within the 12 weeks preceding the study visit.
  10. Pregnancy or breastfeeding.
  11. Respiratory disease or infection.
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

Corticosteroids (steroids)

Anti-inflammatory medicines such as prednisone, prednisolone and dexamethasone — not the anabolic steroids used for muscle.

Studies differ in what they allow: check which steroid medicines, routes (tablets, injections, creams, inhalers, eye drops) and doses this study accepts.

05

Study design

Phase
Not applicable
Primary purpose
Basic science
Allocation
Randomized
Intervention model
Crossover assignment
Masking
Double (Investigator, Outcomes assessor)
Enrollment
20 participants (estimated)

Study arms

  • Experimental
    Low Fiber Diet, Then High Fiber Diet

    Participants will receive a whole food dietary fiber product to consume 10g of dietary fiber per day over a total of 3 days, equal to a high fiber diet. After a washout period of 3 weeks, they then receive the same whole food dietary fiber product, to consume 40g of dietary fiber per day in a total of 3 days, equal to a high fiber diet.

    Other: Low, High Fiber Diet

  • Experimental
    High Fiber Diet, Then Low Fiber Diet

    Participants will receive a whole food dietary fiber product to consume 40g of dietary fiber per day over a total of 3 days, equal to a high fiber diet. After a washout period of 3 weeks, they then receive the same whole food dietary fiber product, to consume 10g of dietary fiber per day in a total of 3 days, equal to a high fiber diet.

    Other: High, Low Fiber Diet

Interventions

  • OtherLow, High Fiber Diet

    Dietary Intervention: Low Fiber Diet Whole food dietary fiber product, 10g of dietary fiber consumed per day for 3 days Dietary Intervention: High Fiber Diet Whole food dietary fiber product, 40g of dietary fiber consumed per day for 3 days

  • OtherHigh, Low Fiber Diet

    Dietary Intervention: High Fiber Diet Whole food dietary fiber product, 40g of dietary fiber consumed per day for 3 days Dietary Intervention: Low Fiber Diet Whole food dietary fiber product, 10g of dietary fiber consumed per day for 3 days

06

What researchers measure

Primary outcomes

  1. Effect of a 3-day low fiber diet compared to a 3-day high fiber diet on the Volatile Organic Compound profiles in exhaled breath

    Volatile Organic Compound profiles in produced by the 3-day low fiber diet intervention compared to the profiles produced by the 3-day high fiber diet, with a 3-week washout inbetween

    Time frame: 5 weeks

Secondary outcomes

  1. Effect of a low fiber diet on Volatile Organic Compound profiles after 4 hours

    Volatile organic compound profiles 4 hours after the start of the low fiber diet intervention compared with baseline (0 hours)

    Time frame: 4 hours

  2. Effect of a low fiber diet on Volatile Organic Compound profiles after 6 hours

    Volatile organic compound profiles 6 hours after the start of the low fiber diet intervention compared with baseline (0 hours)

    Time frame: 6 hours

  3. Effect of a low fiber diet on Volatile Organic Compound profiles after 8 hours

    Volatile organic compound profiles 8 hours after the start of the low fiber diet intervention compared with baseline (0 hours)

    Time frame: 8 hours

  4. Effect of a high fiber diet on Volatile Organic Compound profiles after 4 hours

    Volatile organic compound profiles 4 hours after the start of the high fiber diet intervention compared with baseline (0 hours)

    Time frame: 4 hours

  5. Effect of a high fiber diet on Volatile Organic Compound profiles after 6 hours

    Volatile organic compound profiles 6 hours after the start of the high fiber diet intervention compared with baseline (0 hours)

    Time frame: 6 hours

  6. Effect of a high fiber diet on Volatile Organic Compound profiles after 8 hours

    Volatile organic compound profiles 8 hours after the start of the high fiber diet intervention compared with baseline (0 hours)

    Time frame: 8 hours

  7. Gastrointestinal pH after a 3-day low fiber diet

    Assessment of Gastrointestinal pH measured by the alpHaONE JSPC-1 pH capsule, after a 3-day low fiber diet

    Time frame: 5 weeks

  8. Gastrointestinal pH after a 3-day high fiber diet

    Assessment of Gastrointestinal pH measured by the alpHaONE JSPC-1 pH capsule, after a 3-day high fiber diet

    Time frame: 5 weeks

Other outcomes

  1. Fecal Volatile Organic Compound profiles

    Changes in fecal Volatile Organic Compound profiles produced during fecal fermentation, comparison of baseline (0 hours) profiles with profiles at 24 hours

    Time frame: 1 week

  2. SCFA

    Changes in SCFA levels produced during fecal fermentation, comparison of baseline (0 hours) levels with levels at 24 hours

    Time frame: 1 Week

  3. Microbial enzymatic activity

    Changes in microbial enzymatic activity during fecal fermentation, comparison of baseline (0 hours) activity with activity at 24 hours

    Time frame: 1 week

  4. Microbiota composition

    Microbiota composition at baseline (0 hours) compared with composition at 24 hours

    Time frame: 1 week

07

Study locations

1 of 1 sites recruiting
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jun 4, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT07594600
Lead sponsor
Örebro University, Sweden
Collaborators
University of Helsinki, European Innovation Council
Responsible party
Sponsor
First posted
May 19, 2026
Start date
May 25, 2026 (estimated)
Primary completion
Nov 2026 (estimated)
Completion
Mar 2027 (estimated)
Last update
Jun 4, 2026

Study contacts

Natalie Sundberg PhD Student
Contact
natalie.sundberg@oru.se
+46 704670585
Robert Brummer, Professor
Contact
Robert.Brummer@oru.se
+46 738426600
Robert Brummer, Professor
study director · Örebro University, Sweden

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion